GENE ONLINE|News &
Opinion
Blog

Series A Funding
Ablaze Pharma Launches with $75 Million to Bring Targeted Radiotherapies into China
2021-12-01
Chroma Medicine Debuts with High Hopes for “Game-Changing” Epigenetic Genome Editors
2021-11-17
SK Biopharm Spinout Launches with $180 Million to Bring Neuroscience Drugs to China
2021-11-12
Parthenon Therapeutics Launches with $65 Million Series A to Advance Immuno-Oncology Treatment
2021-11-07
858 Therapeutics Launches with $60 Million Series A for Advancing Small-Molecule Drugs
2021-09-23
Replicate Bioscience Secures $40 Million in Series A to Advance RNA Therapeutics
2021-09-10
GenScript’s Biotech Unit, ProBio Bags $150 Million in Series A from Hillhouse Capital
2021-08-20
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
Singapore’s Esco Secures $200M in Oversubscribed Series A to Develop Cell and Gene Therapy Equipments
2021-05-28
With $41.9 Million from Oversubscribed Financing Round, XyloCor Sets Sights on Gene Therapy for Heart Disease
2021-03-23
Looking to Overcome Limitations in Gene Therapy Space, PBM Capital Backed Startup Launches with $20 M in Series A
2021-03-02
Jaguar Launches with a Pre-clinical Pipeline of AAV9-Based Gene Therapies
2021-02-28
Orna Therapeutics Brings to Market New Therapy to Treat Cancer and Other Diseases
2021-02-26
Ensoma Enters Gene-Editing Market with $70 Million Funding and Takeda Partnership
2021-02-12
Philadelphia Based Biopharma Raises $88 Million in Series A Financing
2021-01-07
1 2
LATEST
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!